MacroGenics
MGNX
#9151
Rank
C$0.15 B
Marketcap
C$2.49
Share price
-5.18%
Change (1 day)
-43.58%
Change (1 year)

MacroGenics (MGNX) - Total assets

Total assets on the balance sheet as of September 2025 : C$0.36 Billion

According to MacroGenics's latest financial reports the company's total assets are C$0.36 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

MacroGenics - Total assets on balance sheet (from 2012 to 2025)

Total assets by year

Year Total assets Change
2024-12-31C$0.37 B-5.14%
2023-12-31C$0.39 B4%
2022-12-31C$0.38 B-10.92%
2021-12-31C$0.42 B-11.53%
2020-12-31C$0.48 B18.32%
2019-12-31C$0.40 B-9.79%
2018-12-31C$0.45 B-3.75%
2017-12-31C$0.47 B12.38%
2016-12-31C$0.41 B-16.07%
2015-12-31C$0.49 B146.98%
2014-12-31C$0.20 B50.71%
2013-12-31C$0.13 B150.52%
2012-12-31C$53.44 M-16.17%
2011-12-31C$63.75 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
C$284.14 B 76,989.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$156.46 B 42,348.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$122.70 B 33,191.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$79.68 B 21,517.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$176.35 B 47,744.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$131.89 B 35,683.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$1.18 B 220.88%๐Ÿ‡บ๐Ÿ‡ธ USA